Biostage, Inc. announced that it expects it will receive $0.6 million in funding from Dst Capital LLC, and another investor

Biostage, Inc. announced that entered into securities purchase agreement for a private placement of 300,000 common shares at a price of $2 per share for gross proceeds of $600,000 in its first tranche on June 17, 2021. The transaction included participation from returning investor DST Capital LLC and individual investor Bin Li. The company also issued warrants to purchase 150,000 shares.

The Warrants have an exercise price of $2 per share and are exercisable until five years from the Warrants' issuance date. The securities will be issued pursuant to exemption provided under Regulation D and exemptions provided by Section 4(a)(2) of the Securities Act.